Cargando…
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
Hepatocellular carcinoma (HCC) is the most commonly diagnosed liver cancer with limited treatment options and extremely poor prognosis worldwide. Recently, the proteolysis targeting chimeras (PROTACs), which aim to induce proteasome-mediated degradation of interesting proteins via recruiting E3 liga...
Autores principales: | Deng, Yuanfei, Yu, Cuifu, Chen, Lushi, Zhang, Xin, Lei, Qiucheng, Liu, Qing, Cai, Gengxi, Liu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114478/ https://www.ncbi.nlm.nih.gov/pubmed/35600879 http://dx.doi.org/10.3389/fphar.2022.858901 |
Ejemplares similares
-
Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014) -
Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma
por: Liu, Rui, et al.
Publicado: (2019) -
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
por: Liao, Yuning, et al.
Publicado: (2023) -
Isoalantolactone Induces Cell Cycle Arrest, Apoptosis and Autophagy in Colorectal Cancer Cells
por: Li, Junkui, et al.
Publicado: (2022) -
Theabrownin Induces Cell Apoptosis and Cell Cycle Arrest of Oligodendroglioma and Astrocytoma in Different Pathways
por: Fu, J. Y., et al.
Publicado: (2021)